Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients

Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients

Objective: The aim of this study was to explore the tolerance, variability, and pharmacokinetics (PK) of albumin-bound paclitaxel (QL, HR, ZDTQ) among Chinese breast cancer patients.Methods: Three randomized, open-label, two-period crossover bioequivalence studies were conducted with albumin-bound p...

Full description

Bibliographic Details
Main Authors: Qingmei Li, Hong Zhang, Xiaoxue Zhu, Chengjiao Liu, Min Wu, Cuiyun Li, Xiaojiao Li, Lei Gao, Yanhua Ding
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Pharmacology
Subjects:
cancer
albumin-bound
paclitaxel
bioequivalence
variability
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01372/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2018.01372/full

Similar Items